通过增加TCR信号强度,TIGIT干扰挽救了低性TCR工程T细胞的抗瘤活性

Martina Spiga1, Alessia Potenza1, Zulma Magnani1

  • 1Experimental hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Nature communications
|January 8, 2026
PubMed
概括

淘汰TIGIT可以增强低贪性T细胞.